FDA alerts providers to COVID-19 rapid test recall
The Food and Drug Administration last week announced a Class 1 recall of two COVID-19 tests the agency had not authorized or approved. Due to the potential for false results, FDA said health care providers and testing programs should consider retesting patients with an authorized test if they administered the CovClear COVID-19 Rapid Antigen Test less than two weeks ago and suspect an inaccurate result, or administered the ImmunoPass COVID-19 Neutralizing Antibody Rapid Test and suspect a recent or prior COVID-19 infection.
Related News Articles
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…
Headline
The Food and Drug Administration’s independent Nonprescription Drugs Advisory Committee Sept. 12 by unanimous vote declared oral phenylephrine…
Headline
The Senate Health, Education, Labor and Pensions Committee today 17-3 to pass as amended the Pandemic and All-Hazards Preparedness and Response Act (S. 2333),…
Headline
The Food and Drug Administration’s vaccine advisory committee June 15 voted unanimously to recommend updating the current COVID-19 vaccine composition for…
Headline
The first data on the safety of a third mRNA COVID-19 vaccine dose among young children show that a third dose is safe for children ages 6 months to 5 years…